C4 Therapeutics Inc
(CCCC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,540 | -22,705 | -11,912 | -34,099 | -24,076 |
| Depreciation Amortization | 1,489 | 857 | 416 | 1,929 | 1,173 |
| Accounts receivable | 482 | -3,923 | 1,303 | N/A | 83,846 |
| Accounts payable and accrued liabilities | -133 | 462 | -2,100 | N/A | 3,071 |
| Other Working Capital | -7,369 | -10,289 | -5,584 | 84,982 | 87,049 |
| Other Operating Activity | 4,415 | 4,338 | 1,211 | 2,802 | -85,145 |
| Operating Cash Flow | $-45,656 | $-31,260 | $-16,666 | $55,614 | $65,918 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -135,979 | -103,942 | N/A | N/A | 0 |
| PPE Investments | -359 | -75 | -184 | -1,286 | -1,422 |
| Other Investing Activity | 0 | 0 | 0 | -334 | 0 |
| Investing Cash Flow | $-136,338 | $-104,017 | $-184 | $-1,620 | $-1,422 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,973 | 11,973 | N/A | N/A | N/A |
| Common Stock Issued | 764 | 232 | 156 | N/A | 206 |
| Common Stock Repurchased | -937 | -851 | N/A | N/A | -40 |
| Other Financing Activity | 143,079 | 141,026 | 0 | 244 | 0 |
| Financing Cash Flow | $154,879 | $152,380 | $156 | $244 | $166 |
| Beginning Cash Position | 93,126 | 93,126 | 93,126 | 38,888 | 38,888 |
| End Cash Position | 66,011 | 110,229 | 76,432 | 93,126 | 103,550 |
| Net Cash Flow | $-27,115 | $17,103 | $-16,694 | $54,238 | $64,662 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,656 | -31,260 | -16,666 | 55,614 | 65,918 |
| Capital Expenditure | -359 | -75 | -184 | N/A | -1,422 |
| Free Cash Flow | -46,015 | -31,335 | -16,850 | 55,614 | 64,496 |